Collaborate Disseminate
OpenEvidence and Johns Hopkins Medicine partner to develop AI tools for physician training and clinical care, with a focus on medical reasoning and patient safety.
The post OpenEvidence, Johns Hopkins Partner to Bring AI Into Medical Training and Patie… Continue reading OpenEvidence, Johns Hopkins Partner to Bring AI Into Medical Training and Patient Care
In an effort to do the right thing for their health, around 17 million US adults could actually be getting poor blood pressure readings from at-home kits that aren’t fitted correctly. This potentially has serious implications for nearly 7% of American … Continue reading Millions of US adults may be getting wrong blood pressure reads at home
Scientists have developed a promising new drug that could prevent and even reverse the onset of type 1 diabetes. The experimental monoclonal antibody drug acts like a shield to protect insulin-producing cells from damage, even extending lifespan in som… Continue reading Experimental antibody drug prevents and even reverses diabetes onset
Omalizumab, currently used to treat asthma, has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure. Wh… Continue reading Asthma drug staves off food allergies in up to 68% of patients
Affecting more than 51 million Americans, chronic pain is more common than other long-term conditions such as depression and diabetes.Continue ReadingCategory: Medical, ScienceTags: Johns Hopkins Medicine, Chronic, Pain Continue reading Scrambler therapy greatly relieves chronic pain in up to 90% of patients
Researchers have designed a new nanoparticle that was shown to more effectively deliver a cancer-fighting mRNA vaccine to mice. The study’s results may lead to the development of better vaccines to treat cancer and infectious diseases like COVID-19.Con… Continue reading New nanoparticle design may improve mRNA vaccine treatments for cancer
A new study using microparticle therapy to boost the number of ‘good’ immune cells has reversed the nerve cell damage in mice with multiple sclerosis-like symptoms and cured more than a third. The finding has the potential to lead to new treatments for… Continue reading Microparticle therapy reverses MS in 100% of mice, cures one third
Clumps of misfolded proteins that gather in the brain have been linked to neurodegenerative diseases like Parkinson’s. Now, newly identified nanobodies show promise in destabilizing the structure of these clumps, potentially leading to new treatments for the disease.
Tags: Parkinson’s Disease, Neuroscience, Johns Hopkins Medicine, University of Michigan, Protein, Brain, antibodies
Continue reading Nanobody treatment could help clear brain protein clumps in Parkinson’s
Scientists at Johns Hopkins have identified a previously unknown mechanism of cocaine’s activity in the brain, which could open new types of treatment for addiction to the drug. Intriguingly, it seems to work differently in male and female mice.Continu… Continue reading Cocaine receptor found in brain could lead to new addiction treatments
New research led by a team from Johns Hopkins Medicine has found no evidence statin use can reduce a person’s risk of severe COVID-19 or death. Countering several small studies suggesting statins may be somewhat protective against severe COVID-19, the … Continue reading Statins unlikely to prevent severe COVID-19, Johns Hopkins study finds